TearScience, Inc.’s LipiFlow® Multi-center Clinical Study Shows Improved Meibomian Gland Secretions and Dry Eye Symptoms
3/5/2012 7:38:57 AM
MORRISVILLE, N.C.--(BUSINESS WIRE)--The results of a randomized, controlled clinical study of a new treatment for Meibomian Gland Dysfunction (MGD) and evaporative dry eye disease, using the LipiFlow® Thermal Pulsation System, was reported in Cornea to provide sustained improvement, on average, in both signs and symptoms. Further, this study demonstrated the clinical utility, safety and effectiveness of LipiFlow® in adult patients with MGD and dry eye symptoms.
comments powered by